Literature DB >> 9581562

Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein.

C Rydén1, H S Tung, V Nikolaev, A Engström, A Oldberg.   

Abstract

Bone sialoprotein is a glycoprotein of the bone and dentine extracellular matrix. This protein consists of 320 amino acids, of which 25% are glutamic and aspartic acid residues. Sialic acid, containing oligosaccharides and tyrosine sulphate residues, supplies additional polyanionic properties. Staphylococcal cells, isolated from patients suffering from infection of bone tissue, bind the bone-derived sialoprotein, an interaction which is specifically inhibited by the recombinant bone sialoprotein core protein. We have previously shown that the 150 N-terminal amino acid residues of bone sialoprotein are responsible for the binding to staphylococcal cells. By using recombinant deleted variants of bone sialoprotein and synthetic peptides, we have now localized the staphylococcal binding site to less than 10 residues within the N-terminal part of the protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581562      PMCID: PMC1218863          DOI: 10.1042/bj3270825

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase.

Authors:  P Kuusela; T Vartio; M Vuento; E B Myhre
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

2.  Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis.

Authors:  C Rydén; I Maxe; A Franzén; A Ljungh; D Heinegård; K Rubin
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

3.  Domain structure of the carboxyl-terminal half of human plasma fibronectin.

Authors:  M Hayashi; K M Yamada
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

4.  Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin.

Authors:  T Vartio
Journal:  Eur J Biochem       Date:  1982-04-01

5.  Differences in domain structures between plasma and cellular fibronectins.

Authors:  M Hayashi; K M Yamada
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

6.  Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus.

Authors:  D F Mosher; R A Proctor
Journal:  Science       Date:  1980-08-22       Impact factor: 47.728

7.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria.

Authors:  G M Vercellotti; J B McCarthy; P Lindholm; P K Peterson; H S Jacob; L T Furcht
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

9.  Binding sites for streptococci and staphylococci in fibronectin.

Authors:  P Kuusela; T Vartio; M Vuento; E B Myhre
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Binding of collagen to Staphylococcus aureus Cowan 1.

Authors:  P Speziale; G Raucci; L Visai; L M Switalski; R Timpl; M Höök
Journal:  J Bacteriol       Date:  1986-07       Impact factor: 3.490

View more
  9 in total

1.  Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts.

Authors:  M Jevon; C Guo; B Ma; N Mordan; S P Nair; M Harris; B Henderson; G Bentley; S Meghji
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals.

Authors:  Tatsuo Yamamoto; Soshi Dohmae; Kohei Saito; Taketo Otsuka; Tomomi Takano; Megumi Chiba; Katsuko Fujikawa; Mayumi Tanaka
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

3.  A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family.

Authors:  H s Tung; B Guss; U Hellman; L Persson; K Rubin; C Rydén
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 4.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

5.  Antibodies to Staphylococcus aureus bone sialoprotein-binding protein indicate infectious osteomyelitis.

Authors:  Lena Persson; Christian Johansson; Cecilia Rydén
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

Review 6.  Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance.

Authors:  Tatsuo Yamamoto; Akihito Nishiyama; Tomomi Takano; Shizuka Yabe; Wataru Higuchi; Olga Razvina; Da Shi
Journal:  J Infect Chemother       Date:  2010-03-25       Impact factor: 2.211

7.  Genomic Characterization of a New Biofilm-Forming and Adhesive ST398 Human-Adapted MSSA Lineage Causing Septic Knee Arthritis Following Surgical Reconstruction.

Authors:  Viviana Cafiso; Flavia Lo Verde; Alessandra Zega; Giuseppe Pigola; Roberto Rostagno; Silvio Borrè; Stefania Stefani
Journal:  Microorganisms       Date:  2021-02-02

8.  Clonal distribution of bone sialoprotein-binding protein gene among Staphylococcus aureus isolates associated with bloodstream infections.

Authors:  Katarzyna Wiśniewska; Anna Piórkowska; Joanna Kasprzyk; Marek Bronk; Krystyna Świeć
Journal:  Folia Microbiol (Praha)       Date:  2014-05-15       Impact factor: 2.099

9.  Synovial bone sialoprotein indicates aseptic failure in total joint arthroplasty.

Authors:  André Busch; Marcus Jäger; Florian Dittrich; Alexander Wegner; Stefan Landgraeber; Marcel Haversath
Journal:  J Orthop Surg Res       Date:  2020-05-27       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.